Novo Nordisk (NVO), the maker of blockbuster weight-loss and diabetes drugs Wegovy and Ozempic, has entered an agreement with ...

injections developed to control diabetes and now also used for weight loss. Her journey began conventionally enough. She’d ...

Hims weight loss plans start at $199 per month ... Seltzer and Nastasi agree most people in their practices gain weight back ...

A trial, targeted at people living with obesity from Britain to Puerto Rico, is the first head-to-head comparison of the ...

An injection pen of Zepbound ... dynamics will again be in focus when Novo reports results for its diabetes drug Ozempic and ...

The drug semaglutide, sold under the brand name Ozempic for diabetes management and Wegovy for weight loss ... While it ...

The millennial-skewed telehealth platform Hims & Hers (HIMS) announced Monday that it will start offering customers a generic ...

There’s been lots of attention on type 2 diabetes drugs recently, especially since they might also be able to support weight ...

Drugs Ozempic and Wegovy have slimmed down Hollywood stars — and millions of non-celebrities worldwide— while adding great ...

Viking Therapeutics (VKTX) released new clinical trial data on Sunday for its experimental weight-loss drugs, which include a highly anticipated oral pill.

It is a sign that Novo Nordisk’s efforts to ramp up the supply of those drugs are starting to pay off, as demand continues to ...

People who received weekly injections of semaglutide -- the active agent in the diabetes drug Ozempic and the weight-loss ...